Lionco Pharmaceutical Group Co., Ltd.SSE: 603669

Announcement on Abnormal Fluctuations in Stock Trading

· Issued by Lionco Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

Lionco Pharmaceutical Group Co., Ltd. has issued an announcement regarding abnormal fluctuations in its stock trading. The company's stock experienced significant price declines over three consecutive trading days, which qualifies as abnormal trading activity according to exchange rules. The company confirmed that its production and operational status remains normal and that there are no undisclosed significant matters affecting stock prices. Investors are advised to be cautious and make informed decisions due to the trading risks associated with these fluctuations.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Lionco Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Lionco Pharmaceutical

Later from Lionco Pharmaceutical

All Lionco Pharmaceutical news releases